AI Writing Tools for Doctors: What You Can Use, What Needs Review, and What to Never Automate

AI writing tools - ChatGPT, Gemini, Claude, Perplexity, and a growing number of India-specific health-tech variants - are already on the desks of Indian doctors. The question is no longer whether to use them, but which writing tasks they are suited for and which they can quietly put patients at risk.

This article introduces a practical traffic-light framework: Green (AI drafts, the doctor publishes after a light check), Amber (AI drafts, the doctor reviews carefully before any use), and Red (never automate, regardless of convenience or time pressure). It maps this framework against India's specific regulatory context - the National Medical Commission's professional conduct rules, the Digital Personal Data Protection Act 2023, and the ABDM ecosystem - so that practitioners can make defensible decisions, not guesses.

After reading this, you will be able to identify precisely which writing tasks in your practice are AI-safe today, which require a careful human hand, and which should stay entirely off the AI workbench. You will also have a one-page checklist you can hand to your administrative team.

---

Dr. Ananya Krishnan is a 41-year-old gynaecologist running a mid-sized clinic in Pune's Kothrud neighbourhood. She sees 30–35 patients on a full day, dictates referral notes between consultations, answers WhatsApp messages from patients on her commute, and tries to maintain a Google Business profile that her front-desk coordinator last updated eight months ago. On a Thursday evening in February, one of her patients - a 28-year-old with a recent ovarian cyst diagnosis - sends a WhatsApp message asking what she should expect after the procedure. Dr. Krishnan is already at home. She opens ChatGPT on her phone, types a quick prompt, reads the response, decides it sounds right, and forwards it to the patient with her name at the bottom.

Nothing went wrong this time. But the conditions for something going wrong were fully in place.

The response ChatGPT produced was based on general population data about ovarian cyst procedures. It did not know this patient's specific cyst type, her age-related risk profile, her comorbidities, or the particular surgical approach Dr. Krishnan used. Had the patient acted on one of those generic instructions - a dietary recommendation, a warning sign to ignore, a timeline to return to activity - and experienced a complication, the forwarded WhatsApp message with Dr. Krishnan's name would sit in the patient's phone as documentation that her doctor told her something she never actually assessed.

This scenario - the time-pressured forward - is not an extreme case. It is the modal way AI writing tools enter clinical practice. Not through a deliberate adoption decision, not through a pilot programme, not even through a conscious experiment. Through convenience, at 9 pm, when the inbox is full and the brain is tired. Across Indian cities, practitioners are using AI to draft patient education content, referral summaries, discharge notes, social media posts, and even consent-adjacent language, often without any internal policy about which category each document belongs to.

The problem is not that AI writing tools are bad. Several are genuinely useful for the routine, high-volume writing that drains clinical time without adding clinical value. The problem is that the same interface - a chat box, a prompt, a plausible-sounding response - is being used indiscriminately across tasks that carry profoundly different risk profiles. A blog post about monsoon diet for diabetics and a post-operative instruction sheet have nothing in common in terms of the harm that can follow from an error. Using the same workflow for both is like applying the same sterility standard to a blood draw and washing your hands before lunch.

---

India's healthcare landscape makes AI writing tool misuse particularly consequential. Sharma et al. (2025), in a large-scale study of 5,061 PM-JAY eligible individuals across seven Indian states (published in Global Health Action, PMC11998304), found that 48.0% of respondents used private outpatient facilities as their primary care source - nearly three times the 18.3% using public outpatient services, and 23.1% reporting no regular outpatient care at all. What this means in practice: the patient's primary relationship with healthcare is not through a coordinated system with medical records, referral trails, and institutional accountability. It is through individual practitioners, often in single-doctor or small-group private clinics, where the doctor's written output - a WhatsApp message, a printed instruction sheet, a prescription note - may be the only documentation of clinical guidance the patient ever receives.

India crossed 800 million smartphone users in 2024, with a median population age of 29. This is not a country where digital health communication is an edge case - it is the dominant mode for a generation of patients who expect to receive post-consultation follow-up by message, find health information on YouTube before they come in, and share their discharge instructions with family members via WhatsApp. The writing a doctor produces digitally now has an audience and a permanence that a verbal consultation never did.

The regulatory environment is catching up, but slowly. The National Medical Commission's professional conduct regulations govern what doctors can claim in advertising and public communication, but they do not yet specifically address AI-generated content. What they do establish - clearly and with disciplinary force - is that a doctor is responsible for any professional communication made under their name. The defence "an AI wrote it" does not exist in NMC's framework. Similarly, the Digital Personal Data Protection Act 2023 (DPDPA) places obligations on any "data fiduciary" processing personal data - and a doctor who pastes a patient's name, diagnosis, or contact information into a commercial AI platform's chat interface has almost certainly processed personal data through a third-party system without the patient's informed, specific consent.

The Ayushman Bharat Digital Mission (ABDM) and its ABHA health ID framework represent a long-term shift toward structured health records in India. As this ecosystem matures, the clinical documentation habits practitioners build today - including how they use AI to assist with that documentation - will interact with an increasingly formal digital health record infrastructure. Practices that develop careless AI documentation habits now will face harder retrofitting later. The stakes for getting the framework right are not only regulatory in the present tense; they are architectural for where Indian healthcare documentation is heading.

---

The most systematic review of AI-generated medical text quality comes from a 2023 study in JAMA Internal Medicine, where physicians evaluated ChatGPT-generated responses to patient health questions and rated them as empathetic and of higher perceived quality than many physician responses - but also found that a meaningful proportion of AI responses contained factual inaccuracies that could mislead patients. This is a US-based study, directionally applicable to India, and it surfaces the core tension: AI-generated health text often reads as authoritative while embedding non-trivial error rates. The study did not assess how those errors would manifest in a clinical context specific to Indian disease profiles, drug formularies, or treatment protocols.

A 2024 analysis published in npj Digital Medicine examined the performance of large language models on clinical documentation tasks - specifically the generation of discharge summaries, referral letters, and patient-facing instruction documents. Researchers found that LLMs produced structurally coherent documents in a large majority of cases, but that clinically significant omissions (missed contraindications, absent follow-up instructions, incorrect dosage framing) appeared in approximately 22% of outputs when models were given minimal clinical context. This is a global study, directionally applicable to India, with the caveat that the drug names, dosage conventions, and clinical pathways studied were primarily Western. Indian practitioners must assume the error rate on India-specific pharmacology and treatment protocols is at least as high, and possibly higher, given the distribution of training data for most commercial LLMs.

Emerging work on AI "hallucination" in high-stakes text generation (directionally applicable to India) has found that large language models are statistically more likely to produce plausible-sounding but incorrect content when asked to generate text about specific, verifiable facts - like drug dosages or contraindication profiles - than when producing general, narrative-style explanations. This matters enormously for clinical writing. Documents like prescription instructions or referral summaries require precise, verifiable facts - which is exactly the category where AI errors are most common and most consequential.

The FICCI-EY Parthenon report (October 2025), an industry report surveying over 1,000 patients and 100+ clinicians across India (note: industry report, not peer-reviewed), found that 83% of surveyed patients aspired to have accessible, reliable health information available to them outside of consultations. This is an aspiration figure, not a behavioural measure - it does not tell us that patients are currently acting on AI-generated health content. But it contextualises the demand environment. Doctors who communicate clearly and reliably in writing are meeting a genuine patient need. The same report noted that patients rely heavily on "informal proxies like brand reputation and word-of-mouth" when choosing providers, which signals that the quality of a doctor's written communication serves both a clinical and a trust-building function.

Indian AI diagnostics companies - Niramai (breast cancer screening), Qure.ai (chest X-ray analysis), and Tricog (ECG interpretation) - have demonstrated that AI can achieve diagnostically meaningful performance in specific, constrained tasks. These are not writing tools; they are image analysis systems trained on carefully curated clinical datasets with specific validation methodologies. They are relevant here as a contrast: the AI writing tools most doctors are reaching for (general-purpose LLMs) have not been trained specifically on Indian clinical data, validated against Indian treatment standards, or certified for clinical output under any Indian regulatory framework. The gap between Qure.ai's validated chest X-ray AI and ChatGPT drafting a post-operative instruction sheet is far larger than the similar-sounding technology category might suggest. Validated diagnostic AI and general-purpose writing AI are not on the same footing, and treating them as equivalent is a category error with clinical consequences.

---

The following section is Influx Health's interpretation and opinion, not research.

Working across 60+ Indian healthcare organisations - from single-doctor GP clinics in Tier 2 cities to multi-specialty hospital networks in metros - we have watched the adoption of AI writing tools follow a consistent and somewhat alarming arc. In the first phase, a doctor or their marketing coordinator uses an LLM to write social media posts and patient education content. This goes well. The content is decent, it saves time, no one is harmed. In the second phase, emboldened by that success, the same tool gets used for the next writing task, and the one after that, without any framework distinguishing what those tasks are. By the time we engage with a clinic, it is often already in Phase 2, and the question of which AI-generated content has actually gone out - and to whom - is genuinely difficult to answer.

The pattern we find most concerning is not the dramatic failure - the AI-generated consent form, the wrong drug instruction forwarded to a patient. Those, mercifully, are still rare. The more prevalent risk is the silent accumulation of low-quality AI output in places that matter. Referral notes that are structurally complete but medically vague. Patient follow-up messages that give reasonable-sounding generic advice that does not match the patient's actual situation. Clinic FAQ pages with information that was accurate in 2023 but does not reflect a recently updated treatment protocol. None of these are catastrophic individually. Cumulatively, they erode the quality of the documentary record a practice maintains, and they erode patient trust when the guidance proves wrong.

One finding from our work that the research largely misses: the administrative team is often the hidden variable. In many clinics we have worked with, it is not the doctor using the AI tool - it is the receptionist or coordinator, often on their personal phone, generating patient communication on the doctor's behalf. The doctor sees a WhatsApp response go out with their name on it and assumes a staff member drafted it in the usual way. They do not know an LLM was involved. Building a coherent AI writing policy for a clinic means building it for the entire team, not just the consulting physician.

A final observation: the doctors who are most comfortable with AI writing tools are not always the ones using them most carefully. Comfort with the technology sometimes produces overconfidence in the output. The practitioners who are slightly wary - who read the AI draft with a skeptical eye - often produce better final documents than those who have learned to trust the fluency of the output. Fluency is not accuracy. An AI writing tool writes with equal confidence whether it is right or wrong. The discipline of review cannot be delegated to the tool itself.

---

A five-step framework for integrating AI writing tools into a clinical practice without increasing documentation or liability risk.

C - Classify the document zone before you prompt Before you open an AI writing tool, decide which traffic-light zone the document belongs to. Green: routine patient education content, appointment reminders, general health tips for social media - AI can draft, you publish after a light read. Amber: clinical summaries, referral notes, prescription instructions, post-procedure guidance - AI can assist, but you must review carefully, fact-check every clinical claim, and edit before sending. Red: clinical diagnoses in writing, consent documents, any document that could be used as stand-alone medical advice - do not automate, full stop. Classify before you prompt, not after you read the output; the plausibility of the AI's response should not influence which zone the document belongs to.

L - Limit patient data in every prompt Never paste a patient's name, phone number, ABHA ID, diagnosis, or any other personally identifiable information into a commercial AI platform's chat interface. The DPDPA 2023 does not provide a clear safe harbour for processing patient data through third-party AI systems without explicit consent. Draft prompts using anonymised clinical scenarios: "Write post-operative instructions for a 35-year-old female patient recovering from laparoscopic ovarian cystectomy, no complications, discharged on day 2" - not "Write instructions for Priya Mehta who I operated on today." This single habit eliminates the most acute privacy risk from AI writing tool use in one step.

E - Edit every AI draft; own the output Under NMC professional conduct rules, a doctor is responsible for any professional communication bearing their name. There is no regulatory defence that attributes authorship to an AI tool. Treat every AI draft as a first draft from a knowledgeable but overconfident junior colleague - read it, edit it, verify every clinical claim, and sign off only when you would be comfortable defending every sentence. Do not forward, publish, or file any AI-generated document unreviewed, regardless of time pressure.

A - Audit your team's AI use quarterly The most dangerous AI writing tool use in most practices is not the doctor's - it is the administrative team acting without a clear policy. Establish a quarterly check: what AI tools is the team using, for which writing tasks, and is that consistent with the clinic's traffic-light classification? A 15-minute team review every three months costs far less than managing one patient complaint about inaccurate written guidance. Make the policy explicit, written, and accessible to every staff member who handles patient communication.

R - Reject AI for red-zone documents, always The Red category is not a risk-tolerance question - it is a bright line. Clinical diagnoses in writing, consent documents, post-procedural instructions for high-risk or surgical cases, any document that a patient might use as a substitute for direct medical advice: these must not be AI-generated, even as a draft you then edit. The reason is not that you cannot fix an AI draft of a consent form. The reason is that the cognitive mode of editing a coherent-sounding document is fundamentally different from the cognitive mode of constructing one from scratch. Red-zone documents require the practitioner's full clinical attention from the beginning. Starting from an AI draft shifts that mode toward light review, and review misses things that construction catches.

---

• This week: Review the last five patient-facing written communications your clinic sent. Classify each one as Green, Amber, or Red using the CLEAR framework. If any Red or Amber documents were AI-generated without careful review, correct the process immediately - not after the next incident.

• This week: Write a one-paragraph AI writing policy for your clinic that specifies which staff members may use AI tools, for which document categories, and what review step is required before anything goes to a patient. Post it in the staff workspace where everyone can see it.

• This month: Audit every prompt template your team currently uses for AI-generated patient communication and remove any that include patient names, contact details, diagnoses, or procedure specifics. Replace with anonymised clinical scenario language that achieves the same result without DPDPA exposure.

• This month: Set a recurring 15-minute quarterly AI audit in your calendar - check what tools the team is using, for what tasks, and whether output is being reviewed before it reaches patients.

• Ongoing: For any Amber-zone document (referral letters, clinical summaries, post-procedure instructions), establish a two-step habit: AI drafts, you review with the specific patient's chart open in front of you. Never review an AI-generated clinical document from memory.

• Ongoing: Subscribe to NMC professional conduct updates and DPDPA implementation guidelines. Neither framework is static, and AI-specific guidance is likely to emerge within the next 12–18 months. A practice that has already built a classification framework will adapt easily; a practice with no policy will scramble.

---

Q: Is using ChatGPT to write patient education content actually illegal under DPDPA?

It depends on what you include in the prompt. If you are writing a generic article about hypertension management for your clinic's website - no patient names, no individual data - you are not processing personal data and DPDPA is not triggered. The moment you include anything that identifies a specific individual (name, phone number, a diagnosis linked to a person, appointment details), you are processing personal data through a third-party system. DPDPA 2023 requires a lawful basis for such processing and, for sensitive data like health information, explicit consent is the relevant basis. No standard commercial AI platform's terms of service constitute a valid consent mechanism for your patient's personal health data. The practical rule: keep AI prompts fully anonymised and you avoid the DPDPA exposure entirely.

Q: My referral notes are already reviewed by me before sending - is it really a problem if AI drafts them?

It depends on how you review. If you read the AI draft while the patient's chart is open, fact-check every clinical claim against what you actually found and documented, and edit substantively before sending - that is Amber-zone use done correctly. The risk is in the review mode: a coherently written AI draft lowers the cognitive alert threshold. Doctors who review AI-drafted referral notes spend less time on each note than they would constructing one from scratch, and the research evidence places AI-drafted clinical summaries at approximately 22% for clinically significant omissions given minimal clinical context. Review with the chart open and treat every AI-drafted clinical detail as unverified until you personally confirm it.

Q: What about AI tools marketed specifically for Indian doctors - are they safer than ChatGPT?

They may be, but "marketed for Indian doctors" is not the same as "validated for Indian clinical use." Look for three things before trusting any AI writing tool with Amber-zone documents: first, whether the tool stores your prompts or patient data, and what its data processing terms are relative to DPDPA; second, whether it has been trained on Indian clinical data and validated against Indian treatment standards; and third, whether its error rate on clinical documentation tasks has been independently tested and published. General-purpose LLMs are transparent about being general-purpose. Some India-specific health-tech AI tools imply clinical specialisation without backing it with published validation. Neither category gets a pass on the review step.

Q: NMC rules on advertising - what exactly applies to AI-generated social media content?

NMC's professional conduct and etiquette regulations prohibit doctors from making false or misleading claims, from using patient testimonials in advertising, and from implying guaranteed outcomes. These rules apply regardless of whether you or an AI wrote the content - the doctor publishing it is responsible for its compliance. In practice, any AI-generated social media post or health education content you publish needs to be checked for: unqualified outcome claims; anything that reads as a diagnosis recommendation for a specific condition; implicit patient testimonials or case presentations that could identify individuals; and comparative claims against other practitioners. The NMC framework was not written with AI-generated content in mind, but its liability logic - the doctor is responsible for what goes out under their name - applies completely.

Q: If I use AI to draft content and something goes wrong, what is my actual legal exposure?

Indian medical liability law has not yet produced case law specifically addressing AI-generated clinical content. But the existing framework - consumer protection law, the NMC disciplinary process, civil negligence principles - operates on the standard of care. If a document bearing your name contained clinically inaccurate guidance that a patient acted on, the fact that AI generated the draft would be a factor the court or disciplinary body would weigh. It would not automatically exculpate you, and it might compound the finding - a doctor who failed to review AI output before sending it to a patient has arguably demonstrated a lower standard of care than one who made a genuine human error in a document they constructed themselves. In the absence of clear AI-specific law, the conservative and defensible position is to treat every document you publish under your name as your own professional responsibility, regardless of how it was drafted.

---

Internal - Influx Health Institute - Understanding Patient Data Privacy for Indian Doctors: DPDPA Explained - How Indian Patients Find and Evaluate Doctors Online - Your Digital Presence Audit: What Patients See Before They Call

External - Authoritative Sources - National Medical Commission - Professional Conduct, Etiquette and Ethics Regulations: https://www.nmc.org.in/rules-regulations/ - Ministry of Electronics and Information Technology - Digital Personal Data Protection Act 2023: https://www.meity.gov.in/it-act/digital-personal-data-protection-act-2023 - Sharma et al. (2025), "Healthcare utilisation patterns among PM-JAY eligible individuals," Global Health Action: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11998304/

---

Read Next: AI Diagnostic Tools in Indian Clinics: What's Validated, What's Overhyped, and What to Ask Before You Buy - the next article in Center 7, examining image-analysis AI (Qure.ai, Niramai, Tricog) and the criteria for evaluating any AI diagnostic tool before clinical adoption.

Assess Your Practice: Run your free Digital Presence Meter at /dpm - a 90-second scan of how visible, credible, and conversion-ready your practice is online, with a sector-specific benchmark for your city.

Chat with Influx Health: Visit /contact to speak with a practice growth specialist - we work with 60+ Indian healthcare organisations and can help you build an AI writing policy that protects your practice while saving clinical time.

--- ---

# Content Derivatives: Center 7, Article 2

---

Subject line: The WhatsApp forward that could cost you - an AI writing guide for doctors

---

Dear Dr. [Name],

It starts small. A patient messages at 9 pm asking about post-procedure care. You are at home, tired, and ChatGPT is two taps away. The response sounds right. You forward it with your name at the bottom.

Nothing goes wrong. This time.

At Influx Health Institute, we have spent the past year watching AI writing tools enter Indian clinical practices - usually through the side door of convenience, without any policy about what they should and should not be used for. The pattern we keep seeing is consistent: AI adoption starts with social media and patient education content (where it genuinely helps), then quietly spreads to referral notes and clinical summaries (where the risk profile is completely different).

The core insight from our work with 60+ Indian healthcare organisations: the problem is not AI writing tools themselves. It is the fact that the same chat interface looks identical whether you are writing a generic monsoon diet tip for Instagram or drafting post-surgical care instructions for a specific patient. The cognitive mode - type, read, send - is the same. The consequences of an error are not.

This month's article introduces the CLEAR framework, a five-step method for classifying your writing tasks before you reach for AI:

• Green zone: Patient education articles, appointment reminders, social media health tips - AI can draft, you publish after a quick read.
• Amber zone: Referral notes, clinical summaries, post-procedure instructions - AI can assist, but review carefully with the patient chart open.
• Red zone: Clinical diagnoses in writing, consent documents, any document used as stand-alone medical advice - never automate, ever.

The article also addresses the DPDPA exposure most Indian doctors are not aware of: if you are pasting patient details into a commercial AI platform, you are processing personal health data through a third-party system without the required consent mechanism. And it covers the hidden variable most clinic AI policies miss entirely - the administrative team using these tools on the doctor's behalf.

Read the full article here: AI Writing Tools for Doctors

And run your free Digital Presence Meter at influx-health.com/dpm - a 90-second scan of how visible your practice is to patients searching online today.

Warm regards, The Influx Health Institute Research Team

---

AI Writing for Doctors: The Traffic Light Guide (4-minute read)

Most Indian doctors are already using AI writing tools. The question is: for which tasks?

Here is the framework in one page:

GREEN - AI drafts, you approve quickly: 1. Patient education blog posts 2. Appointment reminders 3. General health tips for social media

AMBER - AI drafts, YOU review carefully with chart open: 1. Referral letters and clinical summaries 2. Post-procedure patient instructions 3. Prescription guidance notes

RED - Never automate, no exceptions: 1. Written clinical diagnoses 2. Consent documents 3. Any document used as stand-alone medical advice

Two rules that matter most:

Never paste patient names, diagnoses, or contact details into any AI tool - DPDPA 2023 applies, and there is no safe harbour for health data through commercial platforms without explicit consent.

Under NMC rules, you are responsible for every document that goes out under your name. "AI wrote it" is not a defence.

Your admin team is probably using these tools too, without a policy. That is where most clinics' real risk actually sits.

Full article: influx-health.com/institute/center-7-ai-in-healthcare/ai-writing-tools-for-doctors

---

There is a scenario playing out across Indian clinics right now, and most practitioners do not realise they are in it.

A patient messages at 9 pm. The doctor is home, tired. ChatGPT is right there. The response sounds good. The doctor forwards it with their name attached.

Nothing goes wrong. This time.

The problem is not AI writing tools - several are genuinely useful for the high-volume routine writing that drains clinical time without adding clinical value. The problem is that the same chat interface looks identical whether you are writing a generic monsoon diet tip for your Instagram page or drafting post-surgical care instructions for a specific patient.

Those two tasks have completely different risk profiles. Using the same workflow for both is the documentation equivalent of applying the same sterility standard to a blood draw and washing your hands before lunch.

After working with 60+ Indian healthcare organisations, we have documented a consistent pattern: AI adoption in clinical writing starts with social media and patient education content, where it works well, then quietly spreads to referral notes and clinical summaries, where the research places AI-drafted clinical documents at approximately 22% for clinically significant omissions given minimal clinical context.

The DPDPA 2023 angle is also underappreciated. If you are pasting patient details - names, diagnoses, phone numbers - into a commercial AI platform, you are almost certainly processing personal health data without a valid consent mechanism. NMC's professional conduct framework is equally clear: the doctor is responsible for what goes out under their name.

We have published the CLEAR framework - a one-page traffic-light classification system for every writing task in your practice: what AI can handle, what needs your careful review, and what should never touch an AI tool.

Link in comments.

---

1/ Indian doctors are using AI writing tools every day. Most have no policy for which tasks are safe and which are not. That gap is where patient harm and regulatory liability quietly accumulate. A thread.

2/ The surface problem: AI writes fluently whether it is right or wrong. A post-procedure instruction sheet that is 80% accurate looks identical to one that is 100% accurate. You cannot tell the difference by reading it quickly - and most AI review happens quickly.

3/ The research number to know: one study of AI-drafted clinical documents found clinically significant omissions in approximately 22% of outputs given minimal clinical context. That is not "sometimes wrong." That is one in five clinical documents with a meaningful gap. (npj Digital Medicine, 2024; directionally applicable to India.)

4/ The DPDPA exposure most doctors miss: if you paste a patient's name, diagnosis, or contact details into ChatGPT, Gemini, or any commercial LLM, you have processed personal health data through a third-party system. Under DPDPA 2023, that requires explicit consent you almost certainly do not have.

5/ Under NMC professional conduct rules, the doctor is responsible for every professional communication that bears their name. "An AI wrote it" is not a regulatory defence. It may actually compound a disciplinary finding - you failed to review output before it reached a patient.

6/ The traffic light framework:

GREEN - generic health content, appointment reminders, social media tips: AI drafts, doctor approves quickly.

AMBER - referral notes, clinical summaries, post-procedure instructions: AI drafts, doctor reviews with chart open.

RED - diagnoses in writing, consent documents, stand-alone medical advice: never automate.

7/ The hidden variable most clinics ignore: it is often not the doctor using the AI tool. It is the receptionist or coordinator, on their personal phone, generating patient communication under the doctor's name. Your AI policy needs to cover the whole team, not just you.

8/ The CLEAR method in one line: Classify the zone before you prompt. Limit patient data out of every prompt. Edit every draft and own the output. Audit your team's AI use quarterly. Reject AI for red-zone documents without exception.

9/ What we have observed across 60+ Indian healthcare organisations: the doctors most comfortable with AI tools are not always using them most carefully. Fluency produces overconfidence. The slightly skeptical reader catches more errors than the trusting one.

10/ Full framework, NMC guidance, DPDPA analysis, and an FAQ on your actual legal exposure: influx-health.com/institute/center-7-ai-in-healthcare/ai-writing-tools-for-doctors

Run your free Digital Presence Meter: influx-health.com/dpm

--- Article published by the Influx Health Institute. Influx Health is a patient acquisition agency for healthcare organisations in India.